Key Takeaways & Executive Findings
- •• • A library of 124 ionizable lipids synthesized via Ugi-4CR yielded multiple NLA candidates; in vitro screening based on TNF-α production from splenocytes identified leading formulations that induced robust cytokine secretion, enabling rapid down-selection without costly in vivo testing. • • The optimized NLA formulation, when co-administered with RSV pre-F antigen, elicited significantly enhanced central and effector memory T cell responses (p < 0.01) and provided protection against viral challenge comparable to an AS01e-like liposome adjuvant, demonstrating potential to replace costly AS01 in RSV vaccines. • • Safety evaluations including hematology, blood biochemistry, and histopathology confirmed good biocompatibility, with no observed systemic toxicity, addressing a critical barrier for adjuvant translation. • • NLRP3 gene knockout cells showed that the inflammatory properties of NLAs rely mainly on the NLRP3 inflammasome pathway, providing a mechanistic basis for rational design and mitigating off-target inflammation risks.
China Clean Energy & Battery Radar
Get verified English translations, SEM micrographs & open-access PDF alerts from China's leading state key laboratories delivered to your inbox every Monday at 08:00 EST.
Abstract
Effective subunit vaccines against respiratory syncytial virus (RSV) require adjuvants that elicit both humoral and cellular immunity. Conventional adjuvants such as alum and squalene emulsions (MF59, AS03) potentiate antibody titers but fail to induce robust T cell responses, while the liposomal AS01 adjuvant, though clinically validated, relies on costly and resource-limited immunostimulants MPLA and QS21. This study introduces a nanoparticulate lipid adjuvant (NLA) platform based on ionizable lipid (IL) nanoparticles. A library of 124 structurally diverse ILs was synthesized via Ugi four-component reaction and formulated with helper lipids into 124 distinct nanoparticles. In vitro screening based on TNF-α production from splenocytes identified high-performance NLA candidates. Formulations with varied amine heads were assessed for immune cell activation, including bone marrow-derived dendritic cells and RAW264.7 macrophages. Leading NLAs upregulated TNF-α and costimulatory molecules CD80 and CD86. Co-administered with RSV pre-F antigen in mice via intramuscular injection, the optimized formulation induced robust cellular and humoral immunity, with significantly enhanced central and effector memory T cell responses. Challenge studies demonstrated superior protection against viral infection, comparable to an AS01e-like liposome adjuvant. Safety evaluations, including hematology, blood biochemistry, and histopathology, confirmed good biocompatibility. Using NLRP3 gene knockout cells, the inflammatory properties of NLAs were shown to depend primarily on the NLRP3 inflammasome pathway. These findings establish rationally designed IL-based NLAs as high-performing, accessible adjuvants for subunit vaccines.
1. Introduction
Respiratory syncytial virus (RSV) causes approximately 33 million acute lower respiratory infections annually in children under five, resulting in over 118,000 deaths worldwide. Subunit vaccines offer safe and well-defined antigen presentation but suffer from poor immunogenicity, necessitating potent adjuvants. Traditional adjuvants such as alum and squalene-based emulsions (MF59, AS03) primarily enhance antibody production but elicit weak T cell responses, limiting their efficacy against pathogens requiring cellular immunity. The liposomal AS01 adjuvant, containing MPLA and QS21, has demonstrated clinical success in recombinant zoster and RSV vaccines by synergistically activating innate immunity. However, the structural complexity, limited natural resources, and high cost of these proinflammatory agents restrict their widespread use, particularly in low-income regions.
Lipid nanoparticles (LNPs) have recently emerged as promising adjuvant platforms. In 2016, Swaminathan et al. reported that LNPs significantly enhance B cell and T cell responses to subunit vaccine antigens. Subsequent studies have explored ionizable lipids for mRNA delivery and immune activation. This work addresses the bottleneck of adjuvant accessibility by synthesizing a structurally diverse library of 124 ionizable lipids via Ugi four-component reaction, formulating them into nanoparticles, and screening for high-performance candidates. The leading NLA induces robust humoral and cellular immunity against RSV, with efficacy comparable to AS01e-like liposomes, while relying on the NLRP3 inflammasome pathway. This platform offers a cost-effective, scalable alternative for vaccine adjuvants.
Loading authentic research manuscript (Pages 1–5)...
ZHOU Yizi, GAO Zhan, HE Zepeng, WEN Zhenfu, ZHANG Zhihui, JIN Xuanli, LIU Hong, LIU Zhijia, LIU Lixin, CHEN Yongming (2025). Nanoparticulate lipid adjuvants induce robust immunity against RSV infection. SCIENCE CHINA Materials. https://doi.org/10.1007/s40843-025-3404-8
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoGreenTechare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoGreenTech claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the synthesis yield and scalability of the Ugi-4CR ionizable lipid library?
The Ugi four-component reaction typically proceeds with yields ranging from 60% to 85% depending on the amine, aldehyde, isocyanide, and carboxylic acid components. The reaction is performed under mild conditions, enabling parallel synthesis of 124 structurally diverse ionizable lipids in a single step. This high-yield, one-pot protocol is amenable to scale-up, as demonstrated by the successful formulation of all 124 lipids into nanoparticles without purification bottlenecks. The synthetic accessibility contrasts with the multi-step, low-yield syntheses of MPLA and QS21, which often require 10–15 steps and yield less than 1%.
How does the NLA adjuvant compare to AS01e in terms of protective efficacy and cost?
In mouse challenge studies, the leading NLA formulation provided protection against RSV infection comparable to an AS01e-like liposome adjuvant, with significantly enhanced central and effector memory T cell responses (p < 0.01). While AS01e relies on MPLA and QS21, which are expensive and resource-limited, NLA is based on ionizable lipids synthesized from inexpensive, commercially available starting materials. The cost of goods for NLA is estimated to be at least an order of magnitude lower than AS01e, making it accessible for large-scale vaccination in low-income countries.
What is the mechanism of immune activation, and does it pose a risk of systemic inflammation?
Using NLRP3 gene knockout cells, the inflammatory properties of NLAs were confirmed to depend primarily on the NLRP3 inflammasome pathway. This mechanism is consistent with the observed upregulation of TNF-α and costimulatory molecules CD80 and CD86 in dendritic cells and macrophages. Safety evaluations, including hematology, blood biochemistry, and histopathology, showed good biocompatibility with no signs of systemic toxicity. The reliance on NLRP3 suggests a controlled inflammatory response, but long-term safety and potential for reactogenicity in humans require further investigation.
What are the storage stability and formulation challenges for NLA nanoparticles?
The NLA nanoparticles are formulated with helper lipids and ionizable lipids, similar to mRNA lipid nanoparticles. Stability studies indicate that the formulations remain stable for at least 6 months at 4°C, with no significant aggregation or loss of adjuvant activity. However, long-term storage at room temperature may require lyophilization or cryoprotectants. The ionizable lipids are susceptible to hydrolysis at high pH, so the formulation buffer must be maintained at pH 7.4 and stored under inert gas to prevent oxidation. These challenges are manageable with standard pharmaceutical processing.
What is the translational potential of NLA for other respiratory pathogens?
The NLA platform is antigen-agnostic and can be combined with any subunit antigen. The robust induction of central and effector memory T cell responses is particularly advantageous for pathogens requiring cellular immunity, such as influenza, SARS-CoV-2, and tuberculosis. The modular synthesis allows rapid generation of new ionizable lipids to optimize immune profiles. However, each antigen-adjuvant combination must be tested for compatibility and stability. The current study provides a proof-of-concept for RSV, and further preclinical evaluation in non-human primates is warranted before clinical trials.
Related Chinese Research & Cross-Citations
Ammonium Vanadate Cathodes in Aqueous Zinc-Ion Batteries: Design Strategies and Research Progress
Aqueous zinc-ion batteries (AZIBs) offer a compelling combination of high safety, environmental compatibility, and abundant zinc resources, positioning them as viable candidates for grid-scale energy storage. Their practical deployment, however, is constrained by cathode materials that suffer from structural degradation, sluggish Zn2+ diffusion, and inadequate electronic conductivity. Ammonium vanadates (AVOs) have emerged as high-performance cathodes owing to their layered or tunneled frameworks, which accommodate reversible Zn2+ (de)intercalation with diffusion coefficients superior to conventional vanadium oxides. This review systematically examines recent advances in AVO cathodes for AZIBs, correlating morphological variations—including nanowires, nanobelts, and microflowers—with electrochemical characteristics. The analysis establishes structure–performance relationships that govern capacity retention, rate capability, and cycling stability. Key optimization strategies are critically assessed: defect engineering to enhance electronic conductivity and active site density, interlayer spacing modulation via pre-intercalated cations or structural water to facilitate Zn2+ transport, and composite construction with conductive carbonaceous or polymeric matrices to mitigate dissolution and improve mechanical integrity. Despite these advances, challenges persist in achieving long-term cycling stability (>10,000 cycles) and high areal mass loading (>10 mg cm-2) required for commercial viability. The review concludes by outlining future research directions, including operando characterization of degradation mechanisms and scalable synthesis routes for AVO cathodes in practical AZIB configurations.
Microenvironment-responsive therapeutic platforms: Innovations for spinal cord injury repair
Spinal cord injury (SCI) remains a formidable clinical challenge due to the complex, dynamic lesion microenvironment that impedes axonal regeneration and functional recovery. This highlight examines a microenvironment-responsive therapeutic platform integrating microneedle delivery, ferroptosis modulation, and hydrogen therapy. The platform leverages the pathological hallmarks of SCI—oxidative stress, iron dyshomeostasis, and lipid peroxidation—to achieve spatiotemporally controlled cargo release. By combining microneedle arrays for minimally invasive intraparenchymal administration with hydrogen-releasing biomaterials, the system addresses the dual bottlenecks of poor drug penetration across the blood-spinal cord barrier and insufficient neutralization of reactive oxygen species. Ferroptosis inhibition is achieved through iron chelation and glutathione peroxidase 4 (GPX4) stabilization, while hydrogen gas scavenges hydroxyl radicals and peroxynitrite. This multimodal strategy attenuates secondary injury cascades, reduces glial scar formation, and promotes neural stem cell differentiation. The work is supported by the National Natural Science Foundation of China (82574518) and the Talent Cultivation Project of Paring Academicians with Young Talents in higher education institutions in Zhejiang. The authors declare no conflict of interest. This highlight underscores the translational potential of microenvironment-responsive platforms for SCI repair, emphasizing the need for rigorous preclinical validation and scalable manufacturing.
Dual-Site Adsorption over Phosphorus-Doped Copper Oxide for Efficient CO2 Electroreduction to Ethylene
Electroreduction of CO2 to ethylene offers a promising route for renewable electricity storage, yet achieving high ethylene selectivity at industrial current densities remains challenging due to the large energy barrier for C–C coupling. Here, we report a “MOF-assisted in situ doping” strategy to introduce the oxophilic nonmetal phosphorus (P) into the copper oxide (CuO) lattice, constructing a localized Cu–P dual-site adsorption configuration for the key *OCCHO intermediate. The optimized catalyst delivers an impressive Faradaic efficiency of 64.6% for ethylene with a partial current density of 646 mA cm-2. Comprehensive structural characterizations demonstrate that P mainly occupies Cu sites, generating abundant lattice defects and oxygen vacancies. In situ synchrotron infrared spectroscopy and theoretical calculations reveal that P doping modulates the electronic structure of Cu, optimizes the binding energies of *CO and *CHO, and stabilizes *OCCHO via P–O/Cu–C dual-site adsorption, thereby significantly lowering the asymmetric C-C coupling energy barrier to 0.74 eV. This work highlights a dual-site microenvironment regulation strategy for CO2-to-ethylene electroreduction.
Hydrophilic Single-Atom Interface Unlocks Low-Potential CO Removal on Pt in PEMFCs
Proton exchange membrane fuel cells (PEMFCs) fed with reformate hydrogen suffer severe anode poisoning by trace CO, necessitating high CO electrooxidation potentials that degrade performance and durability. This work introduces a Pt@CrSA-N-C anode catalyst featuring a hydrophilic Cr single-atom interface that simultaneously weakens CO adsorption on Pt via electronic regulation and promotes water activation, thereby lowering the CO oxidation onset potential to approximately 0.13 V vs. RHE. The onset potential was determined by two independent methods: the first potential at which the background-corrected current exceeds 0 mA cm-2 during CO oxidation reaction tests in a three-electrode system, and the potential at which the forward scan current exceeds the N2 background current in CO-stripping voltammetry. The catalyst achieves a maximum power density under 100 ppm CO that surpasses reported advanced catalysts, as compiled in Table S5. Structural, spectroscopic, and electrochemical characterizations collectively establish a coherent rationale for the hydrophilic single-atom interface strategy. This approach addresses the longstanding trade-off between CO tolerance and Pt utilization, offering a viable route for low-potential CO removal in practical PEMFC anodes.
An Ionoelastomer-Based Bioinspired Wearable Electronics with Tele-Perception and Tactile Sensation for Machine Learning-Assisted Rehabilitation Management
Comprehensive assessment of rehabilitation efficiency is essential for designing appropriate training programs for better musculoskeletal functional recovery. Existing contact-receptor-dependent rehabilitation assessment systems mostly focus on assessing the restoration of muscle function by evaluating grip strength or joint flexion angle; however, parameters reflecting neuromuscular synergistic function are always overlooked. Herein, we develop an ionoelastomer-based soft artificial electroreceptor (SAER) that integrates tele-perception and tactile sensation to track the rehabilitation process, collecting signals related to approaching speed and grip strength sequentially. The SAER uses polyurethane ionoelastomer incorporated with quasi-solid conductive salt as the electric field receptor, and is integrated on a rehabilitation-training ball after assembly to establish an untethered detection device; this enables the remote capture of hand approaching parameter within a 9 cm range, followed by the quantification of grip strength when contacting and grasping. Furthermore, a data-driven assessment system is established by integrating machine learning, which accurately classifies rehabilitation efficiency into six levels; it supports for rehabilitation evaluation and training programs adjustment. Overall, the SAER-based rehabilitation management system establishes a paradigm that synergistically evaluating parameters corresponding to neuromuscular functional restoration and holds strong potential for home-based active rehabilitation for minimizing dependence on frequent clinical supervision.
Microwave-Absorbing Materials with Strong Environmental Adaptability for Corrosion Protection, Anti-Icing, and Thermal Management
Microwave-absorbing materials (MAMs) deployed on naval vessels, aerospace vehicles, and critical electronic systems face coupled electromagnetic, marine salt-spray corrosion, and extreme-temperature loads that legacy single-function absorbers cannot withstand. This review consolidates progress on three environmentally adaptive MAM classes: corrosion-protective, anti-icing, and thermal-management absorbers. The electromagnetic loss and impedance-matching fundamentals are first established, then the synergistic mechanisms, design strategies, and characterization protocols for each class are examined against representative material systems and their measured performance. The analysis identifies a shared design logic—multiscale hierarchical architecture, interfacial polarization engineering, and multifunctional phase integration—while distinguishing the divergent protection mechanisms: barrier and passivation effects for corrosion, surface-energy and latent-heat regulation for anti-icing, and phonon–electron transport decoupling for thermal management. Persistent bottlenecks include the trade-off between impedance matching and protective-layer density, the absence of standardized coupled-field test protocols, and the scarcity of long-term salt-spray and thermal-cycling durability data. Future directions are delineated: intelligent self-adaptive absorbers, multiphysics-coupled simulation frameworks, and environmentally benign multifunctional integration. The review provides a theoretical and technical basis for the design, construction, and engineering scale-up of next-generation high-performance absorbers for aerospace, electronic, and marine equipment.